Tyrosine kinase fusion genes in chronic myeloproliferative diseases (original) (raw)

References

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835–3849
   Article CAS PubMed Google Scholar
2. Sawyers CL . Chronic myeloid leukemia N Engl J Med 1999 340: 1330–1340
   Article CAS PubMed Google Scholar
3. Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia Blood 2000 96: 3343–3356
   CAS PubMed Google Scholar
4. Chase A, Huntly BJ, Cross NCP . Cytogenetics of chronic myeloid leukaemia Best Pract Res Clin Haematol 2001 14: 553–571
   Article CAS PubMed Google Scholar
5. Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype Blood 1996 88: 2375–2384
   CAS PubMed Google Scholar
6. Shepherd PC, Ganesan TS, Galton DA . Haematological classification of the chronic myeloid leukaemias Baillières Clin Haematol 1987 1: 887–906
   Article CAS PubMed Google Scholar
7. Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M . BCR rearrangement-negative chronic myelogenous leukemia revisited J Clin Oncol 2001 19: 2915–2926
   Article CAS PubMed Google Scholar
8. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NCP . A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review Leukemia 1995 9: 1628–1630
   CAS PubMed Google Scholar
9. Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM . A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity Blood 1995 85: 1881–1887
   CAS PubMed Google Scholar
10. Macdonald D, Reiter A, Cross NCP . The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1 Acta Haematol 2002 107: 101–107
    Article CAS PubMed Google Scholar
11. Steer EJ, Cross NCP . Myeloproliferative disorders with translocations of chromosome 5q31–35: role of the platelet-derived growth factor receptor beta Acta Haematol 2002 107: 113–122
    Article CAS PubMed Google Scholar
12. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA . FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome Nat Genet 1998 18: 84–87
    Article CAS PubMed Google Scholar
13. Popovici C, Adelaide J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pebusque MJ . Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13) Proc Natl Acad Sci USA 1998 95: 5712–5717
    Article CAS PubMed PubMed Central Google Scholar
14. Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C, Shipley J . The t(8;13)(p11;q11–12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP Hum Mol Genet 1998 7: 637–642
    Article CAS PubMed Google Scholar
15. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Goncalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC . Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome Blood 1998 92: 1735–1742
    CAS PubMed Google Scholar
16. Popovici C, Zhang B, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D, Pebusque MJ . The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1 Blood 1999 93: 1381–1389
    CAS PubMed Google Scholar
17. Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB, Pebusque MJ . FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) Blood 2000 95: 1788–1796
    CAS PubMed Google Scholar
18. Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL, Koduru P, Brody JP, Hawson G, Rodwell R, Doody ML, Carnicero F, Reiter A, Goldman JM, Melo JV, Cross NCP . The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins Blood 2001 98: 3778–3783
    Article CAS PubMed Google Scholar
19. Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billstrom R, Isaksson M, Strombeck B, Olofsson T, Mitelman F, Johansson B . Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL Genes Chromosomes Cancer 2001 32: 302–310
    Article CAS PubMed Google Scholar
20. Mugneret F, Chaffanet M, Maynadie M, Guasch G, Favre B, Casasnovas O, Birnbaum D, Pebusque MJ . The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene Br J Haematol 2000 111: 647–649
    Article CAS PubMed Google Scholar
21. Sohal J, Chase A, Mould S, Corcoran M, Oscier D, Iqbal S, Parker S, Welborn J, Harris RI, Martinelli G, Montefusco V, Sinclair P, Wilkins BS, van den BH, Vanstraelen D, Goldman JM, Cross NCP . Identification of four new translocations involving FGFR1 in myeloid disorders Genes Chromosomes Cancer 2001 32: 155–163
    Article CAS PubMed Google Scholar
22. Guasch G, Ollendorff V, Borg JP, Birnbaum D, Pebusque MJ . 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways Mol Cell Biol 2001 21: 8129–8142
    Article CAS PubMed PubMed Central Google Scholar
23. Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 1994 77: 307–316
    Article CAS PubMed Google Scholar
24. Ross TS, Bernard OA, Berger R, Gilliland DG . Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2) Blood 1998 91: 4419–4426
    CAS PubMed Google Scholar
25. Kulkarni S, Heath C, Parker S, Chase A, Iqbal S, Pocock CF, Kaeda J, Cwynarski K, Goldman JM, Cross NC . Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21) Cancer Res 2000 60: 3592–3598
    CAS PubMed Google Scholar
26. Schwaller J, Anastasiadou E, Cain D, Kutok J, Wojiski S, Williams IR, LaStarza R, Crescenzi B, Sternberg DW, Andreasson P, Schiavo R, Siena S, Mecucci C, Gilliland DG . H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22) Blood 2001 97: 3910–3918
    Article CAS PubMed Google Scholar
27. Magnusson MK, Meade KE, Brown KE, Arthur DC, Krueger LA, Barrett AJ, Dunbar CE . Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia Blood 2001 98: 2518–2525
    Article CAS PubMed Google Scholar
28. Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H . Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution Blood 1997 90: 4271–4277
    CAS PubMed Google Scholar
29. Jiang G, Hunter T . Receptor signaling: when dimerization is not enough Curr Biol 1999 9: R568–R571
    Article CAS PubMed Google Scholar
30. Mason IJ . The ins and outs of fibroblast growth factors Cell 1994 78: 547–552
    Article CAS PubMed Google Scholar
31. Yoon SY, Tefferi A, Li CY . Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow Acta Haematol 2000 104: 151–157
    Article CAS PubMed Google Scholar
32. Heldin CH, Ostman A, Ronnstrand L . Signal transduction via platelet-derived growth factor receptors Biochim Biophys Acta 1998 1378: F79–113
    CAS PubMed Google Scholar
33. Smedley D, Demiroglu A, Abdul-Rauf M, Heath C, Cooper C, Shipley J, Cross NCP . ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5 Neoplasia 1999 1: 349–355
    Article CAS PubMed PubMed Central Google Scholar
34. Wilbanks AM, Mahajan S, Frank DA, Druker BJ, Gilliland DG, Carroll M . TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins Exp Hematol 2000 28: 584–593
    Article CAS PubMed Google Scholar
35. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG . 1996 The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways Proc Natl Acad Sci USA 1996; 93: 14845–14850
    Article CAS Google Scholar
36. McWhirter JR, Galasso DL, Wang JY . A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins Mol Cell Biol 1993 13: 7587–7595
    Article CAS PubMed PubMed Central Google Scholar
37. Ollendorff V, Guasch G, Isnardon D, Galindo R, Birnbaum D, Pebusque MJ . Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation J Biol Chem 1999 274: 26922–26930
    Article CAS PubMed Google Scholar
38. Li S, Couvillon AD, Brasher BB, Van Etten RA . Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling EMBO J 2001 20: 6793–6804
    Article CAS PubMed PubMed Central Google Scholar
39. Ross TS, Gilliland DG . Transforming properties of the Huntingin interacting protein 1/platelet-derived growth factor beta receptor fusion protein J Biol Chem 1999 274: 22328–22336
    Article CAS PubMed Google Scholar
40. Sachsenmaier C, Sadowski HB, Cooper JA . STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation Oncogene 1999 18: 3583–3592
    Article CAS PubMed Google Scholar
41. Tomasson MH, Sternberg DW, Williams IR, Carroll M, Cain D, Aster JC, Ilaria RL Jr, Van Etten RA, Gilliland DG . Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581 J Clin Invest 2000 105: 423–432
    Article CAS PubMed PubMed Central Google Scholar
42. Sternberg DW, Tomasson MH, Carroll M, Curley DP, Barker G, Caprio M, Wilbanks A, Kazlauskas A, Gilliland DG . The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways Blood 2001 98: 3390–3397
    Article CAS PubMed Google Scholar
43. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Hoglund M . BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion Genes Chromosomes Cancer 1997 20: 299–304
    Article CAS PubMed Google Scholar
44. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den BH, Marynen P . Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 1997 90: 2535–2540
    CAS PubMed Google Scholar
45. Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R Jr ., Marynen P, Gilliland DG. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo-and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes EMBO J 1998 17: 5321–5333
    Article CAS PubMed PubMed Central Google Scholar
46. Griesinger F, Podleschny M, Steffens R, Bohlander S, Woermann B, Haase D . A novel BCR-JAK2 fusion gene is the result of a translocation (9;22)(p24;q11) in a case of CML Blood 2000 96: 352a
    Google Scholar
47. Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M, Tanimoto M, Saito H . Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12) Blood 2001 97: 1050–1055
    Article CAS PubMed Google Scholar
48. Hild F, Fonatsch C . Cytogenetic peculiarities in chronic myelogenous leukemia Cancer Genet Cytogenet 1990 47: 197–217
    Article CAS PubMed Google Scholar
49. Wong KF, So CC, Kwong YL . Chronic myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98/HOXA9 fusion Cancer Genet Cytogenet 1999 115: 70–72
    Article CAS PubMed Google Scholar
50. Takeda T, Ikebuchi K, Zaike Y, Mori M, Ohyashiki K, Ikeuchi T . Ph-negative chronic myelocytic leukemia with a complex translocation involving chromosomes 7 and 11 Cancer Genet Cytogenet 1986 21: 123–127
    Article CAS PubMed Google Scholar
51. Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatsch C, Heinze B, Bartram C, Hagemeijer A, Grosveld G . The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features Blood 1992 79: 2990–2997
    CAS PubMed Google Scholar
52. Borrow J, Shearman AM, Stanton VP Jr ., Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9 Nat Genet 1996 12: 159–167
    Article CAS PubMed Google Scholar
53. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD Jr . Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia Nat Genet 1996 12: 154–158
    Article CAS PubMed Google Scholar
54. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL . Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification Science 2001 293: 876–880
    Article CAS PubMed Google Scholar
55. Hochhaus A, Kreil S, Corbin A, La Rosee P, Lahaye T, Berger U, Cross NCP, Linkesch W, Druker BJ, Hehlmann R, Gambacorti-Passerini C, Corneo G, D'Incalci M . Roots of clinical resistance to STI-571 cancer therapy Science 2001 293: 2163
    Article CAS PubMed Google Scholar
56. Barthe C, Cony-Makhoul P, Melo JV, Reiffers J, Mahon FX . Roots of clinical resistance to STI-571 cancer therapy Science 2001 293: 2163
    Article CAS PubMed Google Scholar
57. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J . Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors Science 1997 276: 955–960
    Article CAS PubMed Google Scholar
58. Reichert A, Heisterkamp N, Daley GQ, Groffen J . Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336 Blood 2001 97: 1399–1403
    Article CAS PubMed Google Scholar
59. Peters DG, Hoover RR, Gerlach MJ, Koh EY, Zhang H, Choe K, Kirschmeier P, Bishop WR, Daley GQ . Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia Blood 2001 97: 1404–1412
    Article CAS PubMed Google Scholar
60. Karp JE, Lancet JE, Kaufmann SH, End DW, Wright JJ, Bol K, Horak I, Tidwell ML, Liesveld J, Kottke TJ, Ange D, Buddharaju L, Gojo I, Highsmith WE, Belly RT, Hohl RJ, Rybak ME, Thibault A, Rosenblatt J . Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical–laboratory correlative trial Blood 2001 97: 3361–3369
    Article CAS PubMed Google Scholar

Download references